Showing results (41-50 of 406) with videos related to

Sort By:
Pageof 41
International Journal of Hematology|October 8, 2008
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphomaKatja C Weisel, Eckhart Weidmann, Ioannis Anagnostopoulos, et al.
Annals of the New York Academy of Sciences|March 16, 2007
Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacitiesXingkui Xue, Zhen Cai, Gabriele Seitz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 26, 2019
Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment dataKatja Weisel, Heinz Ludwig, Achim Rieth, et al.
Annals of the New York Academy of Sciences|March 31, 2007
Novel markers for the prospective isolation of human MSCHans-Jörg Bühring, Venkata Lokesh Battula, Sabrina Treml, et al.
Annals of the New York Academy of Sciences|October 3, 2009
Phenotypic characterization of distinct human bone marrow-derived MSC subsetsHans-Jörg Bühring, Sabrina Treml, Flavianna Cerabona, et al.
Haematologica|February 27, 2003
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cellsWichard Vogel, Frank Grünebach, Conrad A Messam, et al.
Journal of Cancer Research and Clinical Oncology|August 15, 2015
Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantationSebastian P Haen, Michael Schumm, Christoph Faul, et al.
Cancers|April 3, 2021
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple MyelomaJakub Radocha, Niels W C J van de Donk, Katja Weisel
Pageof 41